Key points are not available for this paper at this time.
Among men with locally advanced or metastatic prostate cancer, ADT plus abiraterone and prednisolone was associated with significantly higher rates of overall and failure-free survival than ADT alone. (Funded by Cancer Research U.K. and others; STAMPEDE ClinicalTrials.gov number, NCT00268476 , and Current Controlled Trials number, ISRCTN78818544 .).
Building similarity graph...
Analyzing shared references across papers
Loading...
Nicholas D. James
Johann S. de Bono
Melissa Spears
New England Journal of Medicine
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
University College London
King's College London
University of Birmingham
Building similarity graph...
Analyzing shared references across papers
Loading...
James et al. (Sat,) studied this question.
www.synapsesocial.com/papers/69d76c47db9d5e1bf4b8a53a — DOI: https://doi.org/10.1056/nejmoa1702900
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: